Tech Stock News
Friday, March 31, 2023
Ocugen Inc (NASDAQ: OCGN), a biopharmaceutical business absorbed on discerning, evolving, and commercializing gene treatments to cure and mounting a vaccine to save exists from COVID-19, today proclaimed that it had nominated Jubilant HollisterStier of Spokane, Washington as its assembling companion for COVAXIN™ to concoct for potentially viable assembling of […]
Ocugen Inc. (NASDAQ: OCGN) dropped 24% in intraday trading on June 14, 2021, after national shareholder rights litigation firm, The Schall Law Firm announced that it is probing securities laws violation claims on behalf of Ocugen investors. Block & Leviton is also investigating the same matter, and investors that lost […]
The stock of Ocugen Inc (NASDAQ: OCGN) dropped by a margin of 5.23% to eventually settle at about 6.34. The Rosen Law Firm suspects that the company misled its investors and has quickly swung into Investigations. Firm’s efforts The law firm expresses concern over the securities claims, outlining that it […]
Despite the late entry into the development of the Covid vaccine, Ocugen Inc (NASDAQ: OCGN) finds its place in the mid-cap space with revenues of $1.87 billion. Investors can buy this stock at $9.70 before Ocugen submits EUA (Emergency Use Application) for its Covid vaccine – Covaxin to the US […]